Endocrine Gland Disorders – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Endocrine Gland Disorders – Drugs In Development, 2024 report and make more profitable business decisions.
Endocrine gland disorders are medical conditions that affect the function of the endocrine system, which is a network of glands that produce and release hormones that regulate many body processes. Some common endocrine disorders are diabetes, hyperthyroidism, hypothyroidism, Cushing’s disease, and polycystic ovary syndrome (PCOS). These disorders can result from various causes, such as tumors, genetic factors, hormonal imbalances, or autoimmune reactions. Endocrine disorders can cause symptoms such as weight changes, fatigue, mood swings, reproductive problems, and growth abnormalities. Endocrine disorders are diagnosed by blood tests that measure the levels of hormones or other markers in the bloodstream. Treatment options depend on the type and cause of the disorder, but may include medication, surgery, radiation therapy, or lifestyle changes.
The Endocrine Gland Disorders drugs in development market research report provide comprehensive information on the therapeutics under development for Endocrine Gland Disorders, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Endocrine Gland Disorders and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Endocrine Gland Disorders | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 40 molecules, with 39 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Endocrine Gland Disorders therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Endocrine Gland Disorders pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Endocrine Gland Disorders treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Addpharma IncAmphastar Pharmaceuticals Inc
Aprilbio Co Ltd
Arbor Pharmaceuticals LLC
Atropos Therapeutics Inc
Azurity Pharmaceuticals Inc
CaraVan Biologix Inc
Citrine (Shanghai) Co Ltd
Consegna Pharma Inc
Daewon Pharmaceutical Co Ltd
Eiger BioPharmaceuticals Inc
Eton Pharmaceuticals Inc
Generium
Genflow Biosciences Srl
Gubra ApS
HLK Pharmacin LLC
Hyloris Pharmaceuticals SA
Korea United Pharm Inc
Lumos Pharma Inc
LyGenesis Inc
MBX Biosciences Inc
Neurocrine Biosciences Inc
Novartis AG
OMass Therapeutics Limited
PRG S&Tech Inc
ProGeLife SAS
Promomed Rus
Salk Institute for Biological Studies
Scohia Pharma Inc
Shandong Xinhua Pharmaceutical Co Ltd
Ziphius Vaccines NV
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Endocrine Gland Disorders reports